| pubmed-article:10626195 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:10626195 | lifeskim:mentions | umls-concept:C1556094 | lld:lifeskim |
| pubmed-article:10626195 | lifeskim:mentions | umls-concept:C0346647 | lld:lifeskim |
| pubmed-article:10626195 | lifeskim:mentions | umls-concept:C0596382 | lld:lifeskim |
| pubmed-article:10626195 | lifeskim:mentions | umls-concept:C0008838 | lld:lifeskim |
| pubmed-article:10626195 | lifeskim:mentions | umls-concept:C0016360 | lld:lifeskim |
| pubmed-article:10626195 | lifeskim:mentions | umls-concept:C0444889 | lld:lifeskim |
| pubmed-article:10626195 | lifeskim:mentions | umls-concept:C0205195 | lld:lifeskim |
| pubmed-article:10626195 | lifeskim:mentions | umls-concept:C0205179 | lld:lifeskim |
| pubmed-article:10626195 | pubmed:issue | 30 | lld:pubmed |
| pubmed-article:10626195 | pubmed:dateCreated | 2000-1-27 | lld:pubmed |
| pubmed-article:10626195 | pubmed:abstractText | The prognosis of patients with advanced pancreatic cancer is extremely poor. To improve their prognosis, providing effective chemotherapy is necessary. The aim of this study was to evaluate the anti-tumor activity and toxicity of combined chemotherapy (FP therapy) using 5-fluorouracil and cisplatin in Japanese chemo-naive patients with advanced pancreatic cancer. | lld:pubmed |
| pubmed-article:10626195 | pubmed:language | eng | lld:pubmed |
| pubmed-article:10626195 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10626195 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:10626195 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10626195 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10626195 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:10626195 | pubmed:issn | 0172-6390 | lld:pubmed |
| pubmed-article:10626195 | pubmed:author | pubmed-author:KatoTT | lld:pubmed |
| pubmed-article:10626195 | pubmed:author | pubmed-author:OkadaSS | lld:pubmed |
| pubmed-article:10626195 | pubmed:author | pubmed-author:HoshinoMM | lld:pubmed |
| pubmed-article:10626195 | pubmed:author | pubmed-author:YoshinoMM | lld:pubmed |
| pubmed-article:10626195 | pubmed:author | pubmed-author:AriyamaJJ | lld:pubmed |
| pubmed-article:10626195 | pubmed:author | pubmed-author:MiyajiMM | lld:pubmed |
| pubmed-article:10626195 | pubmed:author | pubmed-author:KarasawaEE | lld:pubmed |
| pubmed-article:10626195 | pubmed:author | pubmed-author:OgoshiKK | lld:pubmed |
| pubmed-article:10626195 | pubmed:author | pubmed-author:NoseHH | lld:pubmed |
| pubmed-article:10626195 | pubmed:author | pubmed-author:YoshimoriMM | lld:pubmed |
| pubmed-article:10626195 | pubmed:author | pubmed-author:SuyamaMM | lld:pubmed |
| pubmed-article:10626195 | pubmed:author | pubmed-author:FuruseJJ | lld:pubmed |
| pubmed-article:10626195 | pubmed:author | pubmed-author:OkusakaTT | lld:pubmed |
| pubmed-article:10626195 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:10626195 | pubmed:volume | 46 | lld:pubmed |
| pubmed-article:10626195 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:10626195 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:10626195 | pubmed:pagination | 3244-8 | lld:pubmed |
| pubmed-article:10626195 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:10626195 | pubmed:meshHeading | pubmed-meshheading:10626195... | lld:pubmed |
| pubmed-article:10626195 | pubmed:meshHeading | pubmed-meshheading:10626195... | lld:pubmed |
| pubmed-article:10626195 | pubmed:meshHeading | pubmed-meshheading:10626195... | lld:pubmed |
| pubmed-article:10626195 | pubmed:meshHeading | pubmed-meshheading:10626195... | lld:pubmed |
| pubmed-article:10626195 | pubmed:meshHeading | pubmed-meshheading:10626195... | lld:pubmed |
| pubmed-article:10626195 | pubmed:meshHeading | pubmed-meshheading:10626195... | lld:pubmed |
| pubmed-article:10626195 | pubmed:meshHeading | pubmed-meshheading:10626195... | lld:pubmed |
| pubmed-article:10626195 | pubmed:meshHeading | pubmed-meshheading:10626195... | lld:pubmed |
| pubmed-article:10626195 | pubmed:meshHeading | pubmed-meshheading:10626195... | lld:pubmed |
| pubmed-article:10626195 | pubmed:meshHeading | pubmed-meshheading:10626195... | lld:pubmed |
| pubmed-article:10626195 | pubmed:meshHeading | pubmed-meshheading:10626195... | lld:pubmed |
| pubmed-article:10626195 | pubmed:meshHeading | pubmed-meshheading:10626195... | lld:pubmed |
| pubmed-article:10626195 | pubmed:meshHeading | pubmed-meshheading:10626195... | lld:pubmed |
| pubmed-article:10626195 | pubmed:meshHeading | pubmed-meshheading:10626195... | lld:pubmed |
| pubmed-article:10626195 | pubmed:meshHeading | pubmed-meshheading:10626195... | lld:pubmed |
| pubmed-article:10626195 | pubmed:meshHeading | pubmed-meshheading:10626195... | lld:pubmed |
| pubmed-article:10626195 | pubmed:meshHeading | pubmed-meshheading:10626195... | lld:pubmed |
| pubmed-article:10626195 | pubmed:meshHeading | pubmed-meshheading:10626195... | lld:pubmed |
| pubmed-article:10626195 | pubmed:articleTitle | 5-fluorouracil continuous infusion combined with cisplatin for advanced pancreatic cancer: a Japanese Cooperative Study. | lld:pubmed |
| pubmed-article:10626195 | pubmed:affiliation | Department of Internal Medicine, National Cancer Center Hospital, Tokyo, Japan. | lld:pubmed |
| pubmed-article:10626195 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:10626195 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:10626195 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:10626195 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:10626195 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:10626195 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| pubmed-article:10626195 | pubmed:publicationType | Clinical Trial, Phase II | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10626195 | lld:pubmed |
